Interestingly, in our recent comprehensive proteomic analyses of lymph nodes resected from stage IIIc melanoma patients, several complement proteins (complement C3, clustin and complement component 1Q sub-component-binding protein) were differentially abundant between patients with good (>4 years survival) and poor (<1 year survival) prognoses (n = 33). Here, C3 is linked to melanoma.